| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.7M | -63.0% |
| R&D Expense | $179K | -85.7% |
| SG&A Expense | $22.4M | -20.2% |
| Operating Income | -$15.9M | +72.2% |
| Interest Expense | $1.9M | +68.9% |
| Pre-tax Income | $149.5M | +134.7% |
| Income Tax | $2K | +100.6% |
| Net Income | $149.5M | +134.7% |
| EPS (Basic) | $1.76 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $825K | +22.8% |
| Accounts Receivable | $1.7M | +146.6% |
| Current Assets | $4.1M | +70.2% |
| Total Assets | $61.2M | -3.4% |
| Current Liabilities | $45.6M | -78.7% |
| Long-term Debt | $41.2M | +39.1% |
| Total Liabilities | $81.3M | -85.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.6M | +46.4% |
| Capital Expenditures | $11K | -96.4% |
| Investing Cash Flow | -$9K | -103.2% |
| Financing Cash Flow | $12.9M | -15.1% |
| Free Cash Flow | -$12.6M | +47.1% |
| +126.2% |
| EPS (Diluted) | $1.41 | +121.0% |
| Stockholders' Equity |
| -$9.0M |
| +84.3% |